Concepedia

Rachel B. Keller

RB

Statistics

Publications

10

Citations

605

H-Index

10

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

University of Washington

Broad Institute

Massachusetts General Hospital

Rachel B. Keller is an author at Dana-Farber Cancer Institute specializing in medicine, molecular oncology, and oncology.

Publications per year

2012–2023

10

Publications

10

<i>CTC1</i> Mutations in a patient with dyskeratosis congenita

Rachel B. Keller, Katelyn E. Gagne, G. Naheed Usmani et al. · Pediatric Blood & Cancer · 2012 · 139 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

James M. Cleary, Srivatsan Raghavan, Qibiao Wu et al. · Cancer Discovery · 2021 · 107 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively

Rachel B. Keller, Thao Tran, Shawna M. Pyott et al. · Genetics in Medicine · 2017 · 74 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +11

Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness

Júlia C.F. Quintanilha, Michael H. Storandt, Ryon P. Graf et al. · JCO Precision Oncology · 2023 · 54 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma

Graham M. Strub, Andrew L. Kirsh, Mark Whipple et al. · JCI Insight · 2016 · 51 citations · Full text

Medicine, Oncology, Pathobiology +17

1–5 of 10